Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5268258
Max Phase: Preclinical
Molecular Formula: C46H72FNO4
Molecular Weight: 722.08
Associated Items:
ID: ALA5268258
Max Phase: Preclinical
Molecular Formula: C46H72FNO4
Molecular Weight: 722.08
Associated Items:
Canonical SMILES: C=C(C)[C@@H]1CC[C@]2(NCC[C@]3(O)CC[C@](C)(O)CC3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(C6=CC[C@](CF)(C(=O)O)CC6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
Standard InChI: InChI=1S/C46H72FNO4/c1-30(2)32-13-20-46(48-28-27-45(52)24-21-40(5,51)22-25-45)26-23-42(7)34(37(32)46)9-10-36-41(6)16-14-33(39(3,4)35(41)15-17-43(36,42)8)31-11-18-44(29-47,19-12-31)38(49)50/h11,14,32,34-37,48,51-52H,1,9-10,12-13,15-29H2,2-8H3,(H,49,50)/t32-,34+,35-,36+,37+,40-,41-,42+,43+,44-,45-,46-/m0/s1
Standard InChI Key: MQESIHMUUSRXTJ-LOIBZFJVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 722.08 | Molecular Weight (Monoisotopic): 721.5445 | AlogP: 10.12 | #Rotatable Bonds: 8 |
Polar Surface Area: 89.79 | Molecular Species: ZWITTERION | HBA: 4 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 5 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 4.33 | CX Basic pKa: 10.88 | CX LogP: 5.45 | CX LogD: 5.45 |
Aromatic Rings: 0 | Heavy Atoms: 52 | QED Weighted: 0.19 | Np Likeness Score: 1.93 |
1. Hartz RA, Xu L, Sit SY, Chen J, Venables BL, Lin Z, Zhang S, Li Z, Parker D, Simmons TS, Jenkins S, Hanumegowda UM, Dicker I, Krystal M, Meanwell NA, Regueiro-Ren A.. (2022) Synthesis, Structure-Activity Relationships, and In Vivo Evaluation of Novel C-17 Amine Derivatives Based on GSK3640254 as HIV-1 Maturation Inhibitors with Broad Spectrum Activity., 65 (23.0): [PMID:36441509] [10.1021/acs.jmedchem.2c01618] |
Source(1):